Targazyme, Inc. Announces Receipt of an SBIR Award From the National Institute of Dental and Craniofacial Research for the Development of TZ101 Treated Mesenchymal Stem Cells for Treatment of Oral Mucositis
August 26, 2014 19:09 ET
|
Targazyme, Inc.
SAN DIEGO, CA--(Marketwired - August 26, 2014) - Targazyme, Inc. (formerly America Stem Cell, Inc.), a clinical-stage biopharmaceutical company developing novel enzyme technologies and products to...
Targazyme, Inc. Awarded SBIR Grant From National Eye Institute
July 31, 2014 19:48 ET
|
Targazyme, Inc.
SAN ANTONIO, TX--(Marketwired - July 31, 2014) - Targazyme, Inc. (formerly America Stem Cell, Inc.) a clinical-stage biopharmaceutical company developing enzyme technologies and products to improve...
TargaZyme, Inc. Appoints Christopher Calhoun to Business Advisory Board
June 03, 2014 16:10 ET
|
TargaZyme, Inc.
SAN DIEGO, CA--(Marketwired - June 03, 2014) - TargaZyme, Inc. (formerly America Stem Cell, Inc. or the "Company"), a clinical-stage biopharmaceutical company developing enzyme platform...
Targazyme, Inc. Appoints Dr. Mark W. Schwartz to Board of Directors
March 04, 2014 06:00 ET
|
Targazyme, Inc.
SAN ANTONIO, TX--(Marketwired - March 04, 2014) - Targazyme, Inc. (formerly America Stem Cell, Inc., the "Company") announced today that it has appointed Mark W....
Targazyme, Inc. Selected to Present at 2014 BIO CEO & Investor Conference
February 05, 2014 17:52 ET
|
Targazyme, Inc.
SAN ANTONIO, TX--(Marketwired - February 05, 2014) - Targazyme, Inc. (formerly America Stem Cell, Inc.) has been selected to present at the 2014 BIO CEO & Investor...